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The demographic nature of western society is rapidly changing. In the United States the population is aging and becomingly increasingly diverse (1). Next year, there will not be a majority race among those under 18. By 2060 there will 
be no majority within the entire US population. The implications of these changes are 
enormous and the academic enterprise will not be spared. The work of academia and 
the work force of academia will be forever changed within these ongoing social chang-
es. Data science has the potential to alter the fundamental framework of biomedicine. 
Machine learning and artificial intelligence have the capacity to identify mechanisms 
and associations that may lead to innovations in disease prevention and therapy. Yet 
data science must evolve with the social changes underway. 
In the field of clinical trials the diver-
sity of the investigators and the subjects 
have major impact on the conduct and 
applicability of the trials. Unlike the ex-
perimental nature of clinical trials, data 
science is observational in nature. Yet 
decisions in how data sets are generated 
and analyzed are made by individuals 
and groups of individuals. The thoughts 
and actions of each of those individuals is 
based on their life experiences. As such, 
diversity of the investigative team can 
impact the conduct and outcome of data 
science. In this paper, I will extend the 
importance and challenges of diversity in 
clinical trials and apply it to the new field 
of data science.
In 2018, an editorial in Nature was 
published entitled “When will clinical 
trials reflect diversity”(2). In this essay 
the authors demonstrate the lag between 
social change and inclusiveness in sub-
jects in clinical trials. In spite of federal 
requirements and expectations, clinical 
trial subjects are mainly white and male. 
Yet, it is widely understood that social 
determinants of health are the major 
drivers of health in the United States. As 
such, exclusion of diverse populations in 
clinical trials may result in underpow-
ered studies whose results may not be 
generalizable to the broader population. 
Further, the exclusion of large segments 
of our population from these therapeutic 
trials is not just. 
The reasons for a lack of diversity in 
clinical trials find their roots in social in-
justices throughout our country’s history. 
Historic injustices in medical experimen-
tation have led to significant lack of trust 
among diverse populations. This lack of 
trust has led to challenges in the recruit-
ment of underrepresented communities. 
Furthermore, there are social and finan-
cial barriers that are inherent to inclusion 
in trials. Missing work, lack of transpor-
tation and limited exposure to available 
trials are often cited as barriers. Progress 
to overcome this lack of diversity has 
been slow in spite of the multiple drivers. 
One particular area of focus is to address 
the primacy of diversity of the investi-
8KU MASC 2019 Research Retreat
gative team. Diverse investigators will 
be more suited to design trials and ap-
proaches that favor more inclusion and 
strategies to recruit broader populations. 
The need for diversity of the investigative 
team may also be paramount in develop-
ing diversity in data science. 
Why is it important to have diverse 
investigative teams in data science? First, 
the generation of data bases may be biased 
by the teams that generate them. Having 
a diversity of thought, opinion and back-
ground may limit known and unconscious 
bias that can affect the data sets. Second, 
the analysis of data can be similarly biased 
without a diversity of thought. Third, the 
critical social and medical issues that im-
pact diverse populations who bear the 
greatest burden of social determinants 
can be impacted through data science. The 
likelihood that data science focuses on 
these issues will be enhanced if diverse in-
vestigative teams are developed. Finally, 
the population of majority students in the 
pipeline will certainly decrease. If diverse 
groups are not considered for advanced 
training, the overall workforce in data sci-
ence will suffer.
The rate of societal changes in diver-
sity is noticeably greater than changes in 
diversity in academia. Data from the Na-
tional Science Foundation demonstrate 
that the gap for underrepresented popu-
lations is greater for higher academic de-
grees than entry level degrees, is greater 
for men than women and is greater for 
black and African-Americans than for 
Hispanics and Latinos (3). Furthermore, 
these gaps are greater in the sciences as-
sociated with data science, mathemat-
ics and engineering. These gaps and the 
rates at which they are lessening do not 
suggest that the current problem in di-
versity will be self-limited.
So what strategies might be success-
ful in developing diverse investigative 
teams in data science? Unfortunately, 
the challenges faced by the field of clini-
cal trials are applicable to data science as 
well. Prepared doctoral graduates in ad-
vanced fields of science and technology 
are required. For clinical trials the fields 
are medicine, nursing and biomedical 
studies. In data science it is mathematics, 
engineering, medicine, computer science 
and statistics. As discussed above, major 
challenges remain with a lack of diversity 
in these disciplines.
As the trends in diversity demon-
strate, passive approaches will not be 
successful towards the goal of diverse in-
vestigative teams. Intentional and contin-
uous efforts will be required. Addition-
ally these efforts must be focused at the 
time in which students begin to develop 
aptitudes for STEM fields. In my opinion 
the cornerstones of such programs in-
clude the following:
1. Coordination among centers of 
higher education and communi-
ties of underrepresented minori-
ties to provide valued and cul-
turally competent programs to 
support attainment of education-
al milestones.
2. Exposure of diverse students to 
careers in data science through-
out their pregraduate careers 
preferably with diverse role mod-
els, mentors and sponsors.
3. Coordination with governmental 
and non-governmental organiza-
tions to address social determi-
nants of health, many of which 
act as social determinants of edu-
cation and achievement.
At the University of Kansas Medical 
Center, we have engaged our Kansas 
City, Kansas community through a series 
of programs that attempt to meet the cor-
nerstones defined above. These programs 
start at the earliest stage of development 
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with Project Eagle, a large university run 
Head Start program supporting some of 
the neediest and youngest members of 
our community. Our faculty are engaged 
in multiple programs throughout the 
public K-12 school including a successful 
grant which funds STEM curriculum de-
velopment for our local high schools and 
a summer and Saturday science academy. 
Finally, through the advocacy of our fac-
ulty and staff, we have enabled building 
of sidewalks and grocery stores in food 
deserts in our community.
For students interested in health 
based careers, we have a formal shadow-
ing program, a post bac degree for un-
derrepresented minorities that includes 
a guarantee of medical school admission 
and transition to a prematriculation pro-
gram for successful graduates. Taken 
together, this series of programs creates 
an important mechanism for students to 
meet the educational demands of STEM 
careers. 
The field of data science has the po-
tential to revolutionize academia and our 
society. Yet it is subject to the unconscious 
biases currently present in both. We must 
strive to broaden the diversity of investi-
gators who participate in data science in 
order to avoid the pitfalls currently pres-
ent in the field of biomedical clinical tri-
als. This will require intentional and con-
sistent efforts throughout the educational 
hierarchy and interspersed throughout 
our communities. The future of data sci-
ence is dependent on those efforts.
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